Significance of alpha-fetoprotein levels for detection of early recurrence of hepatocellular carcinoma after hepatic resection

Journal of Surgical Oncology

Volumn 64, Issue 2, 1997, Pages 143-146

  Shirabe, Ken ^a,b   Takenaka, Kenji ^a   Gion, Tomonobu ^a   Shimada, Mitsuo ^a   Fujiwara, Yuh ^a   Sugimachi, Keizo ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

alpha fetoprotein; hepatocellular carcinoma; prognostic factor; recurrence

Indexed keywords

ALPHA FETOPROTEIN;

ADULT; AGED; ANGIOGRAPHY; ARTICLE; BLOOD LEVEL; CANCER RECURRENCE; CANCER SURVIVAL; COMPUTER ASSISTED TOMOGRAPHY; ECHOGRAPHY; FEMALE; HUMAN; LIVER CELL CARCINOMA; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS;

AGED; ALPHA-FETOPROTEINS; CARCINOMA, HEPATOCELLULAR; DISEASE-FREE SURVIVAL; FEMALE; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; POSTOPERATIVE PERIOD; PROGNOSIS;

EID: 0031017944     PISSN: 00224790     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9098(199702)64:2<143::AID-JSO10>3.0.CO;2-7     Document Type: Article

References (13)

1. Shirabe K, Kanematsu T, Matsumata T, Adachi E, Akazawa K, Sugimachi K: Factors linked to early recurrence of small hepatocellular carcinoma after hepatectomy. Hepatology 1991;14:802-805.
2. Nagao T, Inoue S, Yoshimi F, et al.: Postoperative recurrence of hepatocellular carcinoma. Ann Surg 1990;211:28-33.
3. Yamanaka N, Okamoto E, Toyosaka A, et al.: Prognostic factors after hepatectomy for hepatocellular carcinoma: A univarite and multivariate analysis. Cancer 1990;65:1104-1110.
4. Okada S, Shimada K, Yamamoto J, et al.: Predictive factors for postoperative recurrence of hepatocellular carcinoma. Gastroenterology 1994;106:1618-1624.
5. Kanematsu T, Matsumata T, Takenaka K, Yoshida Y, Higashi H, Sugimachi K: Clinical management of recurrent hepatocellular carcinoma after primary resection. Br J Surg 1988;75:203-206.
6. Kanematsu T, Sonoda T, Takenaka K, et al.: Alpha-fetoprotein activity in bile of patients with primary hepatocellular carcinoma. J Exp Clin Cancer Res 1989;8:107-112.
7. Schwartz M: A biomathematical approach to clinical tumor growth. Cancer 1961;14:1272-1294.
8. Collins VP, Loeffler RK, Tivey H: Observation on growth rates of human tumors. Am J Roentgenol 1956;76:988-1000.
9. Kaplan EL, P. Meier: Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:456-481.
10. Gehan E: A generalized Wilcoxon test for comparing arbitrarily singly-censored samples. Biometrika 1965;52:203-223.
11. Utsunomiya T, Matsumata T, Adachi E, et al.: Limitations of current preoperative liver imaging techniques for intrahepatic metastatic nodules of hepatocellular carcinoma. Hepatology 1992; 16:694-701.
12. Ezaki T, Yukaya H, Ogawa Y, et al.: Elevation of alpha-fetoprotein level without evidence of recurrence after hepatectomy for hepatocellular carcinoma. Cancer 1988;61:1880-1883.
13. Nagasue N, Inokuchi K, Kobayashi M, Kanashima R: Serum alpha-fetoprotein in patients following partial hepatectomy. Dig Dis Sci 1980;25:243-247.